全文获取类型
收费全文 | 92篇 |
免费 | 7篇 |
国内免费 | 5篇 |
专业分类
妇产科学 | 5篇 |
基础医学 | 6篇 |
口腔科学 | 4篇 |
临床医学 | 3篇 |
内科学 | 3篇 |
神经病学 | 1篇 |
特种医学 | 1篇 |
外科学 | 5篇 |
综合类 | 31篇 |
预防医学 | 2篇 |
眼科学 | 2篇 |
药学 | 4篇 |
中国医学 | 5篇 |
肿瘤学 | 32篇 |
出版年
2021年 | 1篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 4篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 9篇 |
2012年 | 3篇 |
2011年 | 15篇 |
2010年 | 7篇 |
2009年 | 9篇 |
2008年 | 3篇 |
2007年 | 3篇 |
2006年 | 6篇 |
2005年 | 4篇 |
2004年 | 8篇 |
2003年 | 2篇 |
2002年 | 6篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 1篇 |
排序方式: 共有104条查询结果,搜索用时 15 毫秒
1.
目的:研究大肠癌Lovo细胞上皮钙粘附素(E-Cadherin),神经钙粘附素(N-Cadherin)的表达及常用化学治疗药物对其表达的影响。方法:应用逆转录聚合酶链反应(RT-PCR)法检测大肠癌Lovo细胞E-Cad-herin,N-Cadherin的表达,并通过几种不同的化疗药物(顺铂、吡柔比星、丝裂霉素、5-FU)不同浓度和时间作用后,对E-Cadherin,N-Cadherin表达的影响。结果:不同化疗药物对大肠癌Lovo细胞N=Cadherin表达无影响,高浓度顺铂和高浓度吡柔比星二组出现-Cadherin表达,其它各组未见表达。结论:大肠癌常用的化疗药物无论低浓度持续用药,还是高浓度短时间用药,对大肠癌Lovo细胞N-Cadherin的表达无抑制作用,说明上述药物不能通过抑制N—Cadherin的表达,而起到抗癌作用。高浓度顺铂和吡柔比星二组显示E-Cadherin的表达,表现出抑癌的作用,从而提示在大肠癌化疗时,顺铂和吡柔比星更适合于高浓度短时间应用。 相似文献
2.
目的 探讨CD44v6、E -Cadherin表达与人鼻咽癌裸鼠移植瘤转移的关系。方法 分别将人鼻咽癌细胞克隆株F1在体外与鼠肺块共同孵育及胸内移植 ,然后将带瘤细胞肺块 (Ⅰ组 )和胸内瘤组织块 (Ⅱ组 )各行裸鼠皮下移植 ,并与瘤细胞悬液皮下移植瘤 (Ⅲ组 )比较 ,观察各组移植瘤转移特点。采用免疫组织化学技术检测各组移植瘤回复培养细胞CD44v6和E -Cadherin表达。结果 Ⅰ组和Ⅱ组皮下移植瘤的总转移率和淋巴结转移率均高于Ⅲ组 (其中ⅠvsⅢ ,P <0 .0 5) ;肺转移仅发生在Ⅰ组。这两组移植瘤细胞CD44v6表达水平明显增高 ,其阳性细胞数分别为 (79.7± 5.7) %、(74.1± 3.1 ) % ,第 3组为 (65.6± 4.31 ) %移植瘤转移率与CD44v6高表达密切相关 ;E -Cadherin阳性细胞分别为 (41 .7± 4.9) %、(43.8± 6.4) %和 (2 7.4± 4.9) % ,Ⅰ组、Ⅱ组与Ⅲ组之间比较 ,有显著差异 (P <0 .0 5)。结论 CD44v6的过表达和E -Cadherin功能障碍 ,可能在鼻咽癌侵袭转移中起一定作用。 相似文献
3.
茶多酚诱导膀胱癌细胞凋亡及上调PTEN、E-Cadherin表达的研究 总被引:1,自引:0,他引:1
目的 :探讨茶多酚抑制膀胱癌细胞生长的可能分子机制。方法 :采用MTT法和流式细胞术 ,观察膀胱癌细胞系 (T2 4及SCaBER)经不同浓度的茶多酚处理后对细胞生长以及PTEN、E cadherin蛋白表达的影响。结果 :茶多酚以剂量依赖的方式抑制膀胱癌细胞的生长 ,加入 0、5 0、10 0、2 0 0、4 0 0 μg·ml-1茶多酚的T2 4细胞和SCaBER细胞抑制率分别为 0 %、11 2 %、33 4 %、36 9%、6 7 5 %和 0 %、16 5 %、19 1%、30 3%、31 4 %。流式细胞仪直方图上可见亚二倍体峰 ,癌细胞出现凋亡 ,凋亡率分别为 6 8%、2 5 1%、2 8 6 %、36 6 %、4 1 1%和 2 1 4、2 7 2 %、2 8 5 %、36 8%、4 7 7% ;同时 ,随茶多酚作用浓度的增加 ,出现G1/S阻滞细胞逐渐增多 ,细胞分裂增殖指数 (PI)降低 ;而细胞PTEN蛋白表达水平由 (37 6 6± 0 4 9)、(38 2 8± 0 6 1)逐渐增加至(16 3 92± 3 36 )、(177 36± 10 79) ,E cadherin蛋白表达水平由 (37 5 2± 1 14 )、(38 5 9± 4 2 4 )逐渐增加至 (12 1 86± 1 5 0 ,15 3 5 8± 2 5 1) (P <0 0 1,P <0 0 1)。结论 :茶多酚对T2 4及SCaBER细胞生长具有抑制作用 ,其机制可能是通过上调PTEN蛋白表达影响细胞周期和诱导细胞凋亡。PTEN、E cadherin蛋白表达水平的上调可能具有逆转细胞恶性生 相似文献
4.
Homotypic Adhesion through Carcinoembryonic Antigen Plays a Role in Hepatic Metastasis Development 总被引:2,自引:0,他引:2
Toshiaki Yoshioka Takashi Masuko Hitoshi Kotanagi Osamu Aizawa Yuri Saito Hiroshi Nakazato Kenji Koyama Yoshiyuki Hashimoto 《Cancer science》1998,89(2):177-185
We established a cell line with high metastatic potential to the liver (LS-LM4) after four successive repetitions of splenic injection of liver-metastatic cells in SCID mice. This cell line strongly expressed CEA and showed increased homotypic adhesion as compared with the parent cell line (LS174T). To examine the role of CEA in the increased homotypic adhesion, LS-LM4 cells were treated with anti-CEA antibody and subjected to an in vitro adhesion and aggregation assay. Further, to study the role of CEA in the hepatic metastasis of cells with high metastatic potential, LS-LM4 cells were treated with anti-CEA antibody, and the inhibition of hepatic metastasis after splenic injection in vivo was examined. There was a 62% decrease in the homotypic adhesion of anti-CEA antibody-treated (100 μg/ml) LS-LM4 cells under a Ca2+ -free condition as compared with the control ( P <0.01). Anti-CEA antibody (100 μg/ml) inhibited cell aggregation under a Ca2+ -free condition ( P <0.05). Treatment with anti-E-cadherin antibody (60 μ/ml) plus anti-CEA antibody (100 μg/ml) inhibited cell aggregation more potently than anti-E-cadherin antibody treatment alone in the presence of Ca2+ . In vivo , there was a 75% decrease in the number of hepatic metastatic nodules in the G125 anti-CEA antibody-treated group as compared with the control group ( P <0.01). Similarly, there was a 40% decrease in the diameter of metastatic nodules and there was a 90% decrease in total tumor volume of hepatic metastasis in the G125 anti-CEA antibody-treated group as compared with the control ( P <0.01). These results suggest that increased metastatic potential to the liver is at least partly due to increased homotypic binding mediated by CEA. 相似文献
5.
目的 分析E-cadherin (简称E-CD)在胃癌分化、浸润转移中的作用及其表达的临床意义.方法 应用ABC免疫组化方法研究46例原发性胃癌组织及其转移淋巴结E-CD的表达.结果 54.3%(25/46)的胃癌E-CD表达下降.E-CD的高表达与浸润深度、临床病理分期无关(P>0.05),而与胃癌分化程度,Borrmann分型,淋巴结转移有相关性(P<0.05).另外,27.3%的中高分化胃癌的转移淋巴结E-CD比原发癌灶表达高,而在低分化胃癌中可达69.2%.结论 E-CD表达下降与胃癌浸润、淋巴结转移及胃癌分化密切相关. 相似文献
6.
ObjectiveDespite their similar cellular origin, pleomorphic adenomas (PA) and adenoid cystic carcinomas (ACC) present distinct behaviors. This study aimed to analyze the immunoexpression of E-cadherin in PA and ACC of salivary glands, and to investigate differences in its expression in relation to E-cadherin gene (CDH1) -160C/A polymorphism.DesignTwenty-four PA (15 cell-rich and 9 cell-poor tumors) and 24 ACC (10 tubular, 8 cribriform and 6 solid tumors) were selected for the analysis of pattern of distribution, and cellular localization of E-cadherin. In addition, E-cadherin expression was evaluated using the H-score scoring system. The CDH1 -160C/A polymorphism was investigated by PCR-RFLP.ResultsNo significant differences in pattern of distribution (p = 0.181) and cellular localization (p = 0.192) of E-cadherin were observed between PA and ACC. Comparison of PA and ACC cases revealed a higher median H-score in the latter (p = 0.036). Cell-rich PA presented a higher H-score than cell-poor tumors (p = 0.013), whereas no significant differences in E-cadherin expression were observed between ACC subtypes (p = 0.254). The heterozygous genotype of the CDH1 -160C/A polymorphism was detected in only one PA and one ACC. H-scores for tumors carrying the polymorphism were below the lower quartile of their respective groups.ConclusionsThe results suggest that E-cadherin expression in PA and ACC is mainly related to cellular composition (epithelial cells versus myoepithelial cells) and degree of differentiation of myoepithelial cells in these tumors. The CDH1 -160C/A polymorphism does not seem to significantly influence the expression of E-cadherin in PA and ACC of salivary glands. 相似文献
7.
目的探讨伴微乳头状分化的胃肠道腺癌的临床病理学特征。方法选择2009年1月至2012年12月收治的伴微乳头状分化的胃肠道腺癌50例作为观察组,同期选择普通胃肠道原发腺癌50例作为对照组,观察两组患者的临床病理特征,同时进行EMA、E-Cadherin和IMP3的免疫组织化学分析。结果观察组患者的肿瘤浸润程度和临床分期均显著高于对照组,差异有统计学意义(P<0.05)。观察组患者的EMA表达阳性率为56.0%,对照组患者的EMA表达阳性率为24.0%,差异有统计学意义(P<0.05)。观察组患者的IMP3表达水平高于对照组,而E-cadherin表达水平则明显下降,差异有统计学意义(P<0.05)。结论伴微乳头状分化的胃肠道腺癌具有高侵袭性与高分期的临床特征,可造成EMA和IMP3表达率增加以及E-cadherin表达率降低,提示其有特殊的增殖活性和细胞黏附性。 相似文献
8.
目的 研究槲皮素对肝癌高转移细胞基质粘附能力的影响及其机制.方法 研究对象为人高转移肝细胞癌细胞HCCLM6,用细胞基质粘附实验检测槲皮素对细胞外基质粘附能力的影响,免疫荧光和Western blot 检测细胞内E-Cadherin蛋白表达.结果 槲皮素能抑制肝癌细胞对Marigel胶的粘附,免疫荧光和Western blot检测均发现槲皮素处理组肝癌细胞E-Cadherin蛋白表达较对照组增加(P<0.05).结论 槲皮素能抑制肝癌高转移细胞的基质粘附能力,其机制之一可能在于槲皮素能上调肝癌细胞E-Cadherin蛋白表达. 相似文献
9.
Phui-Ly Liew Chun-Sen Hsu Wei-Min Liu Yu-Chieh Lee Yi-Chih Lee Chi-Long Chen 《International journal of clinical and experimental pathology》2015,8(5):5642-5649
Objectives: Despite considerable interest in the Nuclear factor-erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1), p16 and epithelial cadherin (E-cadherin) activation in carcinoma progression, contradictory results regarding association of Nrf2/Keap1/E-cadherin and p16 expression with clinico-pathological features and prognosis have been reported. The predictive value of these markers in ovarian carcinoma is unknown. Methods/Materials: In this retrospective study, 108 cases were evaluated immunohistochemically with antibodies to Nrf2, Keap1, estrogen receptor (ER), p16 and E-cadherin. The results were compared with histological and clinical data, disease-free survival (DFS) and overall survival (OS). Results: A cohort of 108 ovarian carcinomas (47 serous, 23 mucinous, 13 endometrioid and 25 clear cell), including 68 FIGO stage I-II cases and 40 FIGO stage III-IV cases was studied. The age of patients (P=0.005), FIGO stage (P<0.001), immunohistochemical expression of Keap1 (P<0.000), E-cadherin (P=0.045), p53 (P=0.003), p16 (P<0.001) and ER (P=0.004) were significant factors between different histological subtypes. Patients with serous carcinoma were older in age, presented with more advanced stage disease, worst prognosis, highest Keap1 expression and least percentage of E-cadherin immunoreactivity. In univariate analysis, FIGO staging (P=0.000 for DFS; P=0.000 for OS), Nrf2 (P=0.010 for DFS; P=0.001 for OS), and p16 (P=0.004 for DFS; P=0.019 for OS) were associated with worse prognosis. After multivariate analysis, FIGO staging and Nrf2 remained significance prognostic factors. Conclusions: There were differences in the expression of Nrf2, Keap1, p16 and E-cadherin between different ovarian carcinoma subtypes. In multivariate analysis, FIGO stage and Nrf2 expression were associated with poorer DFS and OS. 相似文献
10.
目的:探讨癌相关蛋白EZH2和钙黏蛋白(E-Cadherin)在子宫内膜异位症大鼠模型异位灶中的表达及意义。方法:根据大鼠自体移植方法构建大鼠子宫内膜异位症模型为实验组(n=15),选取未造模的正常大鼠为对照组(n=10)。应用免疫组织化学法(Elivision法)和Western-blot法检测实验组异位灶内及对照组子宫内膜中EZH2和E-Cadherin的表达情况,并分析两者的相关性。结果:免疫组化检测EZH2在实验组异位灶和对照组子宫内膜组织中阳性表达的平均光密度值分别为(43.10±1.52)和(32.70±1.64),而E-Cadherin在实验组异位灶和对照组子宫内膜组织中阳性表达的平均光密度值分别为(15.70±1.64)和(23.30±1.64),差异均有统计学意义(P0.05)。Western-blot法检测实验组异位灶中EZH2表达量(195.26)明显高于对照组(85.74),而E-Cadherin表达量(24.67)明显低于对照组(92.50),差异均有统计学意义(P0.05)。实验组EZH2与E-Cadherin的表达呈负相关(r=-0.9626,P0.05)。结论:子宫内膜异位症病灶中EZH2高表达都伴随着ECadherin的低表达,且两者呈明显的负相关,EZH2可能通过抑制E-Cadherin的表达促进子宫内膜异位症的发生及发展。 相似文献